VC Cell Therapy
PrivateLast Round
VC Round
Nov 15, 2023
Total Funding Raised
$7.33M
Company Overview
VC Cell Therapy is a biotechnology company that develops regenerative cell therapies for retinal degeneration diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine
Business Model
B2B2C
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
VC Cell Therapy Comps
Public and private peers based on sector, stage, and business model.
VC Cell Therapy Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Nov 15, 2023 | ||||
| Convertible Debt | Apr 1, 2021 |
VC Cell Therapy Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| YASKAWA Electric Corporation | VC Round |
| 株式会社日本政策金融公庫 | Debt |
| Ritsumeikan Social Impact Fund | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 15, 2023
$4M raised from YASKAWA Electric Corporation and others.
- Apr 1, 2021
Raised $5.33M in convertible debt.
VC Cell Therapy Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about VC Cell Therapy's valuation, stock price, and market status.
